Yowler Jennifer
Known title: President, PharMericaCIK: 0001995316
Yowler Jennifer's purchase track record
Yowler Jennifer has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/15/2024 | BTSG | $25K | +27.1% | +68.1% | +10.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| BTSG | ▲ Buy | Grant | 23,029 | $0 | 3/17/2025 | View on chart |
| BTSG | ▼ Sell | Tax Withholding | 8,508 | $194K | 1/25/2025 | View on chart |
| BTSG | ▲ Buy | Open Market | 3,000 | $25K | 3/15/2024 | View on chart |
| BTSG | ▲ Buy | Grant | 57,880 | $0 | 1/26/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
BrightSpring Health Shares Rise Ahead of Q3 Earnings and AI Rollout
BrightSpring Health (BTSG) shares climbed today as the company announced it will report third‑quarter 2026 results on Oct. 30 and outlined plans to expand specialty pharmacy, pursue M&A and deploy AI across operations. The move follows a comparison with Option Care Health that highlighted BrightSpring’s broader service mix. Investors are watching whether the AI initiative will lift margins and support the company’s growth strategy.
BrightSpring Health Shares Rise Ahead of Q3 Earnings and AI Rollout. BrightSpring Health (BTSG) shares climbed today as the company announced it will report third‑quarter 2026 results on Oct. 30 and outlined plans to expand specialty pharmacy, pursue M&A and deploy AI across operations. The move follows a comparison with Option Care Health that highlighted BrightSpring’s broader service mix. Investors are watching whether the AI initiative will lift margins and support the company’s growth strategy.